Innovative therapy access
Uniphar is the global leading expert in advanced therapy access, guiding groundbreaking therapies to support commercialization.
Our expanded access experience has shown how these programs are integral to a successful strategy for advanced therapies.
Our pillars of service
With extensive expertise across the full product lifecycle, we navigate complex scientific, regulatory and operational challenges to deliver tailored solutions that optimize patient access worldwide.
Advanced therapy platform
Our proprietary advanced therapy platform allows us to streamline and optimize strategy from early access to commercialization and sustained market success
Our unrivalled experience spanning multiple advanced therapy access programs, combined with an expert team ensure confidence and success in facilitating patient access world wide
experience to ensure meticulous execution of complex initiatives. Our global platform draws together multifunctional teams and infrastructure for execution excellence
50 countries served
6 years’ advanced therapy experience
500+ patients treated
From our partners

Delivering advanced therapies in a highly regulated environment

Equitable access: How can we make advanced therapies a reality or possibility for all mankind?

The role of expanded access in advanced therapies

Cross-border Expanded Access Programs: Reducing barriers to treatment access

Three key steps to bring EAPs to a global market
Learn more about our service areas
Enabling equitable
access
affairs
Commercial
services for pharma
Your advanced therapy partner
Whether it’s an expanded access program, regulatory approval, reimbursement strategy or commercial launch, we have the agility and vision to stay ahead of the curve in this rapidly evolving landscape.
Trust us to be your partner, unlocking the transformative potential of advanced therapies for patients globally.